Skip to content

Drug interactions

Doxorubicin + Efavirenz

Severity: Minor

Doxorubicin and Efavirenz: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Efavirenz may lower doxorubicin exposure through enzyme induction, which could reduce efficacy. Evidence is limited, as CYP3A4 is only a minor route of doxorubicin elimination.

What this interaction means in plain words

Doxorubicin and Efavirenz have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Doxorubicin belongs to Oncology; Efavirenz belongs to Anti Virals.

Evidence level: Low

Why it happens

Efavirenz induces CYP3A4, which has a minor role in doxorubicin metabolism.

What to do

No routine dose change; monitor oncologic response and toxicity during combined therapy.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Doxorubicin and Efavirenz, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Doxorubicin with Efavirenz?

MediHelp rates the interaction as minor. Doxorubicin and Efavirenz have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Efavirenz may lower doxorubicin exposure through enzyme induction, which could reduce efficacy. Evidence is limited, as CYP3A4 is only a minor route of doxorubicin elimination.

How serious is the interaction between Doxorubicin and Efavirenz?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine dose change; monitor oncologic response and toxicity during combined therapy.

What other medicines interact with Efavirenz?

MediHelp also lists interactions of Efavirenz with, for example, Cobimetinib, Dienogest / estradiol valerate, Dihydroergotamine intranasal. The full list is on the Efavirenz page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in